What were the key changes in the Board of Directors?

At the 2013 Annual Meeting, two directors, Marian L. Heard and Lance Piccolo, retired from the Board, leading to a reduction in the Board's size from 11 to 9 members. Additionally, William C. Weldon, who was elected to the Board in March 2013 and re-elected by stockholders, was appointed to the Management Planning and Development Committee and the Nominating and Corporate Governance Committee.

What was the significance of the amendment to the Certificate of Incorporation?

The company's stockholders approved an amendment to the 'fair price' provision within the Certificate of Incorporation. This amendment modifies the voting thresholds required under this provision, which is relevant for future transactions involving a change in control of the company by potentially raising the bar for certain acquisition scenarios.

What were the outcomes of the shareholder proposals?

All three shareholder proposals presented at the meeting were rejected by the stockholders. These proposals related to requesting a report on political contributions, establishing a policy on accelerated vesting of equity awards upon a change in control, and requesting a report on lobbying activities. The rejection of these proposals indicates that the majority of voting shareholders sided with management's stance on these matters.

Were there any changes to the company's independent auditor?

No, the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the 2013 fiscal year was ratified by the stockholders, meaning they will continue in this role.

CVS 8-K: Leadership Changes, Shareholder Matters & More

Summary

This 8-K filing from CVS Health (then CVS Caremark Corporation) on May 13, 2013, primarily details outcomes from its 2013 Annual Meeting of Stockholders held on May 9, 2013. The most significant event for investors relates to changes in the Board of Directors and an amendment to the company's Certificate of Incorporation. Two directors, Marian L. Heard and Lance Piccolo, retired, leading to a reduction in the Board size from 11 to 9 members. Additionally, William C. Weldon was appointed to two board committees. The filing also confirms stockholder approval for an amendment to the "fair price" provision in the Certificate of Incorporation, which modifies voting thresholds, a move that could have implications for future corporate control transactions. The meeting also saw the approval of routine management proposals, including the ratification of Ernst & Young LLP as the independent auditor, executive compensation (on a non-binding advisory basis), and an amendment to the Employee Stock Purchase Plan to add shares. Importantly, three shareholder proposals concerning political contributions, lobbying reports, and accelerated vesting upon change of control were all rejected by stockholders, indicating management's preference prevailed on these governance matters.

Key Highlights

1Two directors, Marian L. Heard and Lance Piccolo, retired from the Board of Directors at the 2013 Annual Meeting.
2The size of the Board of Directors was reduced from 11 to 9 members following director retirements.
3William C. Weldon was appointed to the Management Planning and Development Committee and the Nominating and Corporate Governance Committee.
4Stockholders approved an amendment to the Certificate of Incorporation to modify voting thresholds under the 'fair price' provision.
5The appointment of Ernst & Young LLP as the independent registered public accounting firm for 2013 was ratified.
6A non-binding advisory vote to approve the compensation of named executive officers was passed.
7Three separate stockholder proposals regarding political contributions, lobbying reports, and accelerated equity vesting upon change of control were rejected.

CVS HEALTH Corp 8-K Report, Executive Changes (May 13, 2013)

Summary

Key Highlights

Frequently Asked Questions